121 related articles for article (PubMed ID: 21880200)
1. The treatment of fetishism in an adolescent with attention deficit hyperactivity disorder.
Chang HL; Chow CC
Chang Gung Med J; 2011; 34(4):440-3. PubMed ID: 21880200
[TBL] [Abstract][Full Text] [Related]
2. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
3. Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.
Fernández-Jaén A; Fernández-Mayoralas DM; Pardos A; Calleja-Pérez B; Muñoz Jareño N
Adv Ther; 2009 Dec; 26(12):1097-110. PubMed ID: 20082241
[TBL] [Abstract][Full Text] [Related]
4. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
Shalev R; Gross-Tsur V
Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
[No Abstract] [Full Text] [Related]
5. An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.
Hergüner S; Tanidir C
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):383-4. PubMed ID: 21823916
[No Abstract] [Full Text] [Related]
6. The possible effect of methylphenidate on secondary encopresis in children with attention-deficit/hyperactivity disorder.
Bilgiç A
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):647. PubMed ID: 21130131
[No Abstract] [Full Text] [Related]
7. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
Wigal SB; Wilens TE; Wolraich M; Lerner M
Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
9. [Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder].
Tomás Vila M; Aleu Pérez-Gramunt M; Beseler Soto B; Benac Prefasi M; Pantoja Martínez J; Pitarch Castellano I
An Pediatr (Barc); 2010 Aug; 73(2):78-83. PubMed ID: 20605120
[TBL] [Abstract][Full Text] [Related]
10. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
Fone KC; Nutt DJ
Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
[TBL] [Abstract][Full Text] [Related]
11. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Zarinara AR; Mohammadi MR; Hazrati N; Tabrizi M; Rezazadeh SA; Rezaie F; Akhondzadeh S
Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068
[TBL] [Abstract][Full Text] [Related]
13. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.
Treceño C; Martín Arias LH; Sáinz M; Salado I; García Ortega P; Velasco V; Jimeno N; Escudero A; Velasco A; Carvajal A
Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):435-41. PubMed ID: 22253017
[TBL] [Abstract][Full Text] [Related]
14. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
Gadow KD; Sverd J
Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
[No Abstract] [Full Text] [Related]
15. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
Golubchik P; Weizman A
Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
[No Abstract] [Full Text] [Related]
16. The effect of methylphenidate and placebo on eye-hand coordination functioning and handwriting of children with attention deficit hyperactivity disorder.
Lufi D; Gai E
Neurocase; 2007 Oct; 13(5):334-41. PubMed ID: 18781432
[TBL] [Abstract][Full Text] [Related]
17. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
18. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
[TBL] [Abstract][Full Text] [Related]
19. Case of a 67-year-old woman diagnosed with ADHD successfully treated with methylphenidate.
da Silva MA; Louza M
J Atten Disord; 2008 May; 11(6):623. PubMed ID: 18417727
[No Abstract] [Full Text] [Related]
20. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
Bental B; Tirosh E
J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
